FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Gangemi

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Disorders

Physiology

Co-author Network

Publications

TOP 3
E Angela Murphy; J Mark Davis; Jamie L McClellan; Martin D Carmichael; Nico Van Rooijen; J David Gangemi
Susceptibility to infection and inflammatory response following influenza virus (H1N1, A/PR/8/34) challenge: role of macrophages.
Mark Davis; Angela E Murphy; J L McClellan; Martin D Carmichael; J David Gangemi
Quercetin reduces susceptibility to influenza infection following stressful exercise.
Jeffrey A Johnson; J David Gangemi
Alpha interferon augments cidofovir's antiviral and antiproliferative activities.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Gangemi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: E Angela Murphy; J Mark Davis; Jamie L McClellan; Martin D Carmichael; Nico Van Rooijen; J David Gangemi
Susceptibility to infection and inflammatory response following influenza virus (H1N1, A/PR/8/34) challenge: role of macrophages.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2011;31(6):501-8.
2008: Mark Davis; Angela E Murphy; J L McClellan; Martin D Carmichael; J David Gangemi
Quercetin reduces susceptibility to influenza infection following stressful exercise.
American journal of physiology. Regulatory, integrative and comparative physiology 2008;295(2):R505-9.
2003: Jeffrey A Johnson; J David Gangemi
Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
Antimicrobial agents and chemotherapy 2003;47(6):2022-6.
1999: Jeffrey A Johnson; H K Hochkeppel; J David Gangemi
IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(10):1107-16.
1999: Jeffrey A Johnson; J David Gangemi
Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Antimicrobial agents and chemotherapy 1999;43(5):1198-205.
1999: A I Hussain; W L Robson; R Kelley; T Reid; J David Gangemi
Mycoplasma penetrans and other mycoplasmas in urine of human immunodeficiency virus-positive children.
Journal of clinical microbiology 1999;37(5):1518-23.
1996: Christian T K-H Stadtländer; J David Gangemi; S S Khanolkar; C M Kitsos; H E Farris; L K Fulton; J E Hill; F K Huntington; C K Lee; T P Monath
Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate.
Digestive diseases and sciences 1996;41(9):1853-62.
1996: Uwe Wintergerst; J David Gangemi; E R Kern; R J Whitley; S Chatterjee
Differential effect of recombinant human and mouse interferons on replication of herpes simplex virus type 1 in mouse cells.
Antiviral research 1996;32(1):27-34.
1994: J David Gangemi; Lucia Pirisi-Creek; M Angell; J W Kreider
HPV replication in experimental models: effects of interferon.
Antiviral research 1994;24(2-3):175-90.
1993: R Sundaram; M O'Connor; M Cicero; Abdul Ghaffar; J David Gangemi; Eugene P Mayer
Lipopolysaccharide-induced suppression of erythrocyte binding and phagocytosis via Fc gamma RI, Fc gamma RII, Fc gamma RIII, and CR3 receptors in murine macrophages.
Journal of leukocyte biology 1993;54(1):81-8.
1993: M A Khan; William H Tolleson; J David Gangemi; Lucia Pirisi-Creek
Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons.
Journal of virology 1993;67(6):3396-403.
1993: S Pyo; J David Gangemi; Abdul Ghaffar; Eugene P Mayer
Poly I:C-induced antiviral and cytotoxic activities are mediated by different mechanisms.
International journal of immunopharmacology 1993;15(4):477-86.
1992: Abdul Ghaffar; Eugene P Mayer; D C Barnhart; S Pyo; S Szymaniec; H K Hochkeppel; J David Gangemi
Cross-species antiviral activity of a recombinant human alpha-interferon hybrid.
Annals of the New York Academy of Sciences 1992;653():314-22.
1991: S Pyo; J David Gangemi; Abdul Ghaffar; Eugene P Mayer
Poly I:C-induced anti-herpes simplex virus type 1 activity in inflammatory macrophages is mediated by induction of interferon-beta.
Journal of leukocyte biology 1991;50(5):479-87.
1991: L M De Castro; E R Kern; E De Clercq; Abdul Ghaffar; Eugene P Mayer; P E Vogt; J David Gangemi
Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.
Antiviral research 1991;16(1):101-14.
1990: Janis Lazdins; E Alteri; K W Cook; C Burgin; J David Gangemi
Use of human monocytes in the evaluation of antiviral drugs: quantitation of HSV-1 cytopathic effects.
Antiviral research 1990;13(4):175-86.
1990: Patrick Midoux; E Negre; Annie-Claude Roche; R Mayer; Michel Monsigny; J Balzarini; E De Clercq; Eugene P Mayer; Abdul Ghaffar; J David Gangemi
Drug targeting: anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine.
Biochemical and biophysical research communications 1990;167(3):1044-9.
1989: J David Gangemi; R M Cozens; E De Clercq; J Balzarini; H K Hochkeppel
9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.
Antimicrobial agents and chemotherapy 1989;33(11):1864-8.
1989: J David Gangemi; A Matter; B Poncioni; H K Hochkeppel
Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections.
Journal of interferon research 1989;9(3):275-83.
1989: J David Gangemi; Janis Lazdins; F M Dietrich; A Matter; B Poncioni; H K Hochkeppel
Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid.
Journal of interferon research 1989;9(2):227-37.
1987: J A Hightower; M G Welsh; R A Jackson; J David Gangemi
An ultrastructural examination of murine alveolar macrophages following intranasal administration of propionibacterium acnes.
Histology and histopathology 1987;2(3):217-22.
1987: J David Gangemi; Maurice Nachtigal; D Barnhart; L Krech; P Jani
Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus.
The Journal of infectious diseases 1987;155(3):510-7.
1986: R A Jackson; P H Lill; J David Gangemi
Role of pulmonary macrophages in resistance to experimental metastasis.
Journal of leukocyte biology 1986;40(5):575-87.
1986: P H Lill; J David Gangemi
Suppressive effects of 3-methylcholanthrene on the in vitro antitumor activity of naturally cytotoxic cells.
Journal of toxicology and environmental health 1986;17(4):347-56.
1985: G N Olsen; J David Gangemi
Bronchoalveolar lavage and the immunology of primary lung cancer.
Chest 1985;87(5):677-83.
1985: J David Gangemi; G N Olsen; C Fechter; J A Hightower; C T Bauguess; L Krech
Phagocytic activity of alveolar macrophages in patients with bronchogenic carcinoma.
Cancer immunology, immunotherapy : CII 1985;20(2):158-66.
1983: J David Gangemi; J A Hightower; R A Jackson; M H Maher; M G Welsh; M M Sigel
Enhancement of natural resistance to influenza virus in lipopolysaccharide-responsive and -nonresponsive mice by Propionibacterium acnes.
Infection and immunity 1983;39(2):726-35.
1980: J David Gangemi; Abdul Ghaffar; R L Trauger; M M Sigel
Natural killer cell activation in lipopolysaccharide-responsive and -non responsive mice by viral and bacterial agents.
Journal of the Reticuloendothelial Society 1980;27(5):525-33.